NOVEL THERAPEUTIC APPROACHES AND TARGETS FOR THE TREATMENT OF IMMUNOMEDIATE AND INFLAMMATORY SKIN DISEASE WITH SYSTEMIC INVOLVEMENT Guest Editor(s): Anna Campanati Tentative Publication Date: December, 2019 Submit Abstract via EmailDownload Description
DISCOVERY OF PROTEIN-TARGETED ANTITUMOR INHIBITORS: BIOCHARACTERIZATION, MOLECULAR MECHANISMS AND PHARMACEUTICAL APPLICATIONS Guest Editor(s): Jianqiang Xu, Jun Lu Tentative Publication Date: October, 2019 Submit Abstract via EmailDownload Description
UTILIZATION OF IPSC TECHNOLOGIES FOR DRUG‐INDUCED RISK AND DRUG EFFICACY EVALUATION DURING DRUG DEVELOPMENT Guest Editor(s): Norimasa Miyamoto Tentative Publication Date: December, 2019 Submit Abstract via EmailDownload Description
Prof. Davide Prosperi is Associate Professor in Biochemistry at the University of Milano Bicocca (Unimib), Department of Biotechnology and Bioscience. Head of the NanoBioLab of Unimib, he is devoted to biomedical and biophysical applications of nanotechnology. In particular, the research activity of Davide Prosperi involves the design, synthesis, functionalization and characterization of colloidal, polymeric and biomimetic nanoparticles for biomedical applications, with particular focus on the diagnosis and treatment of cancer and inflammatory diseases. He is author of over 100 scientific publications. He is one of the author of the patent “Nanoconstructs with pharmacological activity” (n° WO2014013473-A1), and co-founder of the spin-off company inTHEna srl, aiming to design and development of molecules, nanostructures and technologies for biomedical studies and diagnosis, prevention and therapy of human and animal diseases.